Skip to main content
Daily Report

Daily Anesthesiology Research Analysis

01/20/2026
3 papers selected
71 analyzed

Analyzed 71 papers and selected 3 impactful papers.

Summary

Three impactful anesthesiology-related studies stood out today: a single-center RCT found that high-flow nasal oxygenation did not reduce desaturation during infant intubation versus face mask but significantly reduced gastric insufflation; a prospective imaging study using a sigma-1 receptor PET/MRI identified peripheral pain generators in CRPS and guided targeted therapies with meaningful pain reduction; and a preoperative EEG-derived Delirium Index accurately predicted postoperative delirium in elderly hip fracture patients, especially when combined with cognitive and frailty scores.

Research Themes

  • Peri-intubation respiratory support strategies in infants
  • Molecular imaging-guided pain management in CRPS
  • EEG biomarkers for perioperative delirium risk stratification

Selected Articles

1. Identification of peripheral pain generators with sigma-1 receptor Positron Emission Tomography/Magnetic Resonance Imaging in complex regional pain syndrome: initial study in a prospective trial.

73.5Level IVCase series
Pain · 2026PMID: 41557146

In a prospective single-center study of 15 CRPS patients, sigma-1 receptor PET/MRI using [18F]FTC-146 identified focal peripheral pain generators in two-thirds of cases. Targeted treatments informed by PET/MRI led to an average 5-point pain score reduction in 80% of treated patients. These data support molecular imaging to personalize pain interventions in CRPS.

Impact: This is among the first prospective applications of sigma-1 receptor PET/MRI to localize peripheral pain generators in CRPS and to demonstrate management changes with measurable clinical benefit.

Clinical Implications: Sigma-1 receptor PET/MRI may help identify treatable peripheral pain generators in CRPS, enabling targeted interventions (e.g., nerve blocks, ablations) while limiting systemic adverse effects and accelerating response.

Key Findings

  • [18F]FTC-146 PET/MRI identified potential peripheral pain generators in 10/15 CRPS patients.
  • Targeted treatments based on PET/MRI findings produced an average 5-point reduction in pain scores in 80% (8/10) of treated cases.
  • Prospective review of imaging with pain specialists led to management changes guided by abnormal sigma-1 uptake foci.

Methodological Strengths

  • Prospective design with predefined imaging protocol and multidisciplinary review with pain specialists.
  • Use of a highly selective sigma-1 receptor radioligand ([18F]FTC-146) targeting nociceptive/inflammatory processes.

Limitations

  • Single-center, small sample size (n=15) limits generalizability.
  • No randomized control or blinded comparator; outcomes largely based on subjective pain scores.

Future Directions: Conduct multicenter controlled studies to validate diagnostic accuracy, define which CRPS phenotypes benefit most, assess long-term outcomes and cost-effectiveness, and compare against standard imaging.

Complex regional pain syndrome (CRPS) is a poorly understood chronic pain condition of the extremities presenting severe pain disproportionate to the causative injury. Owing to its heterogeneous clinical presentation and the lack of specific diagnostic tests, CRPS is often a diagnostic and therapeutic challenge. Early diagnosis and treatment of CRPS improve quality of life and delay disease progression. Identification of focal peripheral pain generators would provide an opportunity for targeted treatments with more limited side effects. A highly selective sigma-1 receptor positron emission tomography (PET) radioligand, [18F]FTC-146, has been developed and has shown promise in identifying inflammatory or nociceptive processes. Our aim was to investigate the utility of [18F]FTC-146 PET/MRI for identifying peripheral pain generators and assessing its impact on subsequent clinical management of patients with CRPS. This single-center study enrolled 15 subjects with a clinical diagnosis of CRPS to undergo [18F]FTC-146 PET/MRI. PET/MRI findings were reviewed and discussed with referring pain specialists. Pain scores and subsequent changes in pain management for each patient were prospectively noted. Potential pain generators were observed in 10 of 15 subjects. Subsequent pain treatments guided by abnormally increased foci of uptake on [18F]FTC-146 PET/MRI resulted in an average 5-point improvement in pain score in 80% (8/10) of subjects. Overall, [18F]FTC-146 PET/MRI was able to identify potential peripheral pain generators in the affected limbs of subjects with CRPS and subsequently guided targeted treatments that resulted in varying degrees of improvement in subjective pain scores.

2. High-Flow Nasal Oxygenation in Infants Undergoing Tracheal Intubation: A Single-center Randomized Controlled Trial.

72.5Level IRCT
Anesthesiology · 2026PMID: 41557566

In 125 infants undergoing elective intubation, HFNO did not reduce the incidence of desaturation (SpO2 <95%) versus face mask strategies but significantly lowered gastric insufflation. Other secondary outcomes, including severe desaturation, first-pass success, and post-intubation gases, were similar.

Impact: This rigorously conducted RCT provides needed evidence in infants, showing HFNO’s neutral effect on desaturation but a clear reduction in gastric insufflation, informing airway management trade-offs.

Clinical Implications: For infant intubations, HFNO may be selected to reduce gastric insufflation risk without expecting lower desaturation rates compared to face mask ventilation; device choice should prioritize aspiration risk and procedural workflow.

Key Findings

  • Primary outcome: desaturation (SpO2 <95% for ≥5 s) did not differ between groups (9.2% control vs 13.3% HFNO; RR 1.44; 95% CI 0.53–3.92; P=.658).
  • Secondary outcomes (SpO2 <90%, first-attempt success, lowest SpO2, post-intubation ETCO2/ETO2, atelectasis scores) were similar.
  • Gastric insufflation occurred significantly less with HFNO (36.7% vs 70.8%; P<.001).

Methodological Strengths

  • Randomized controlled design with prespecified primary endpoint and standardized oxygenation protocols.
  • Comprehensive assessment of peri-intubation outcomes including gas exchange, desaturation thresholds, and imaging-based atelectasis scores.

Limitations

  • Single-center study may limit generalizability and was potentially underpowered for small differences in desaturation.
  • Exclusions after randomization and lack of blinding are inherent limitations in airway device trials.

Future Directions: Multicenter trials exploring different HFNO flow strategies, peri-intubation timing, and high-risk subgroups (e.g., difficult airways) are warranted.

BACKGROUND: High-flow nasal oxygenation (HFNO) is increasingly used as an alternative for preoxygenation and apneic oxygenation during tracheal intubation. However, its efficacy in infants remains underexplored. We evaluated whether HFNO improves intubation outcomes compared to those with face mask ventilation in infants. METHODS: This prospective, single-center randomized controlled trial included 132 infants undergoing elective surgery under tracheal intubation. The infants were divided into HFNO and control groups, with both groups receiving 100% oxygen. The HFNO group received HFNO for preoxygenation (0.5 L/kg/min for 3 min) as well as during the apneic period (2 L/kg/min for 1 min) and laryngoscopy (2L/kg/min). The control group received face mask preoxygenation (6 L/min for 3 min), followed by face mask ventilation during the apneic period (6 L/min for 1 min) and no oxygen delivery during laryngoscopy. The primary outcome was the desaturation incidence (peripheral oxygen saturation < 95% for ≥5 s) from preoxygenation to 1 min after intubation. Various secondary outcomes were also assessed. RESULTS: After exclusions, 125 infants were analyzed (HFNO: n=60; control: n=65). There was no statistically significant between-group difference in the incidence of oxygen saturation < 95% (control vs. HFNO: 9.2% vs. 13.3%; relative risk, 1.44; 95% confidence interval, 0.53-3.92; P=.658). With regard to secondary outcomes, the incidence of oxygen saturation < 90%, first-attempt intubation success rate, lowest oxygen saturation, post-intubation end-tidal CO2 and O2, and atelectasis scores were similar between groups. Gastric insufflation was less frequent in the HFNO group; the difference was statistically significant (36.7% vs. 70.8%; P <.001). CONCLUSIONS: In the present study involving the use of HFNO for preoxygenation and apneic oxygenation during tracheal intubation in infants, there was no significant difference in the incidence of desaturation between HFNO and face mask ventilation, although the former was associated with less frequent gastric insufflation.

3. EEG-Derived Index Predicts Postoperative Delirium in Elderly Patients With Hip Fracture: A Prospective Study From a Tertiary Medical Center.

70Level IICohort
Brain and behavior · 2026PMID: 41555613

In a prospective cohort of 144 elderly hip fracture patients, a preoperative EEG-derived Delirium Index (DELi) correlated with CAM scores and predicted postoperative delirium with AUC 0.791. Combining DELi with MoCA and FRAIL scores achieved excellent discrimination (AUC 0.922; sensitivity 85.9%, specificity 86.3%).

Impact: This study introduces and validates a quantitative EEG biomarker for POD risk stratification and demonstrates additive value when combined with cognitive and frailty assessments.

Clinical Implications: Preoperative DELi, especially when integrated with MoCA and FRAIL, could identify high-risk patients for targeted delirium prevention strategies (e.g., non-pharmacologic bundles, minimization of deliriogenic medications).

Key Findings

  • DELi correlated with CAM scores (r=0.516; p<0.0001) and predicted POD with AUC 0.791 (95% CI 0.715–0.867).
  • A composite model of DELi + MoCA + FRAIL achieved AUC 0.922 (95% CI 0.878–0.965), sensitivity 85.9%, specificity 86.3%.
  • Prospective cohort design with ROC, logistic regression, and bootstrap validation supports robustness of findings.

Methodological Strengths

  • Prospective cohort with standardized preoperative EEG acquisition and validated POD outcome (CAM).
  • Modeling with ROC, logistic regression, and internal bootstrap validation; demonstration of incremental value with MoCA and FRAIL.

Limitations

  • Single-center study without external validation may limit generalizability.
  • Proprietary EEG-derived index requires reproducibility across devices and processing pipelines; not an interventional study.

Future Directions: External multicenter validation, integration into perioperative workflows, and trials testing whether DELi-guided prevention reduces POD incidence and improves outcomes.

INTRODUCTION: Postoperative delirium (POD) remains challenging to predict in elderly hip fracture patients. This study posited that a newly developed electroencephalogram-derived metric, termed the Delirium Index (DELi), has the potential to elucidate latent information pertaining to the preoperative predisposing factors of POD. METHODS: A prospective cohort of 144 elderly patients undergoing hip fracture surgery was enrolled. DELi scores were derived from preoperative electroencephalography (EEG) using wavelet analysis. POD was diagnosed using the Confusion Assessment Method (CAM). Predictive performance was evaluated via ROC analysis, logistic regression, and bootstrapping validation. RESULTS: DELi demonstrated strong correlation with CAM scores (r = 0.516, p < 0.0001) and good predictive accuracy for POD (AUC = 0.791, 95% CI: 0.715-0.867). A composite model integrating DELi, Montreal Cognitive Assessment (MoCA), and FRAIL scores achieved excellent discrimination (AUC = 0.922, 95% CI: 0.878-0.965), with 85.9% sensitivity and 86.3% specificity. CONCLUSIONS: The DELi index, combined with cognitive and frailty assessments, provides a practical tool for preoperative POD risk stratification in elderly hip fracture patients. TRIAL REGISTRATION: ChiCTR2200060389.